|Loma Linda University Adventist Health Sciences Center|
|City: Loma Linda||State: CA|
Summary: Loma Linda University Adventist Health Sciences Center has an unequivocal gift and meal ban, a good firewall on purchasing decisions, and an important requirement that all consulting and participation at conferences and meetings be pre-approved. This language could be made stronger by explicitly including all speaking engagements in the pre-approval requirement, and banning speaker's bureaus, rather than just warning against them. As this institution seems to recognize samples’ use as a marketing tool, officials there would do well to prohibit their use, or put in place a program that breaks the gifting link between physicians and drug reps, and promotes the used of well-tested, older therapies.
Demographics: On average students spend 70% of their time training at Loma Linda University Medical Center, 20% at Riverside County Regional Medical Center, and 10% at Jerry Pettic VA Medical Center. Submitted policies apply to faculty and students at all sites.
Updates: This institution did not provide any new or additional for the 2012-13 AMSA PharmFree Scorecard.
This institution has not consented to allow the public posting of their policies.
|Gifts & Meals||This institution has established an unequivocal ban on gifts and meals.|
|Consulting relationships||All consulting arrangements must be approved by the institution before initiation, must be documented in a formal contract with specific deliverables, and payment must be commensurate to those deliverables.|
|Industry-funded speaking relationships||Though strong language cautions against the use of speakers bureaus as marketing tools, this institution does not prohibit them. Though the policy does require that all content and its development be under the sole control of the presenter, who must disclose financial support from industry to audience, other firewalls that would limit faculty from having long-standing speaking arrangements with industry are absent.|
|Disclosure||This AMC requires that faculty annually disclose financial relationships if they garner more than $1000 cumulatively, a floor under which there is considerable room for industry influence; furthermore, requiring only faculty to disclose fails to capture industry ties among numerous other individuals involved in medical education, including staff, residents, and adjuncts. The policy cedes further management of disclosures to "cost centers," and clarity on this structure would be useful.|
|Pharmaceutical samples||This institution discourages the use of samples, acknowledging within the policy their use as a marketing tool, but does nothing to actively restrict or regulate their use or acceptance as such.|
|Purchasing & Formularies||Purchasing committee members with financial conflicts must disclose the conflicts to the P&T committee and recuse themselves in all decisions affecting companies and products with which they have an interest.|
|Industry Sales Representatives||Pharmaceutical sales representatives are allowed on-site by appointment only.|
|On-campus Education||All events that receive industry funding, whether or not CME-accredited, must abide by ACCME regulations, including the Standards for Commercial Support. Additionally, industry may not provide food at any CME or other event, and AMC faculty and staff are prohibited from accepting such meals elsewhere|
|Attendance at Industry-Sponsored Lectures & Meetings Off-Campus||Accepting industry payments to attend off-site conferences and events is prohibited. The dept, division or program retains total control over recipients of industry travel support, and the dept. chair must validate the educational worth of an event.|
|Industry Support for Scholarships & Funds for Trainees||This is a strong scholarship policy that prevents earmarking or quid pro quos for industry funds, but an exception that the institution may cede control of choosing recipients for national or regional merit-based scholarships seems unnecessarily broad and could open the door to undue industry influence on scholar selection.|
|Medical school curriculum||No curricular material submitted.|
|Do the policies specify an oversight mechanism?||No oversight stipulated.|
|Are there explicit sanctions for noncompliance?||No sanctions established.|
|Good progress toward model policy|
|No policy, or policy unlikely to have a substantial effect on behavior|
|Did not report|
|Policy not relevant to this institution (e.g., does not make purchasing decisions)|